Gain Critical Insights For Better Decision Making
With the ability to deliver comprehensive particle counting, identification, and characterization on as little as 5 µL of sample, the Aura family of instruments give gene therapy developers and manufacturers critical information while preserving precious samples early in development.
Protein & Antibody
(Viral Vectors, Exosomes, LNPs)
Innovative Technology Enables Early Candidate Characterization and Selection
Unlike flow imaging, which requires milliliters of sample, Aura systems can quickly and easily characterize viral vector and other types of gene therapies with just 5µL of sample. This is due to analyzing samples via membrane microscopy which requires meniscal amounts while maintaining 100% sampling efficiency.
Begin candidate screening and selection much earlier in development providing the confidence needed when commercializing your gene therapy.